Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Profound Medical Corp. shareholders approved Election of eight director nominees to serve until the next annual meeting at the 2026-05-13 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-13
Exact text from the filing
Each of the eight nominees listed below was elected as director of the Company to hold office until the Company's next annual meeting of shareholders or until their successor is duly appointed.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Profound Medical Corp. shareholders approved Ordinary resolution approving all unallocated restricted share units and deferred share units under the Company's long-term incentive plan at the 2026-05-13 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2026-05-13
Exact text from the filing
The shareholders approved an ordinary resolution approving all unallocated restricted share units and deferred share units under the Company's long-term incentive plan.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Profound Medical Corp. shareholders approved Appointment of PricewaterhouseCoopers LLP as auditors of the Company until the close of the next annual meeting at the 2026-05-13 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-13
Exact text from the filing
The shareholders approved the appointment of PricewaterhouseCoopers LLP as auditors of the Company until the close of the Company's next annual meeting of shareholders at such remuneration to be fixed by the Board.
View on SEC.gov